BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25756195)

  • 1. Multilayered HIV-1 gag-specific T-cell responses contribute to slow progression in HLA-A*30-B*13-C*06-positive patients.
    Zhang H; Han X; Zhao B; An M; Wang Z; Jiang F; Xu J; Zhang Z; Dong T; Shang H
    AIDS; 2015 Jun; 29(9):993-1002. PubMed ID: 25756195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A longitudinal analysis of immune escapes from HLA-B*13-restricted T-cell responses at early stage of CRF01_AE subtype HIV-1 infection and implications for vaccine design.
    Zhang H; He C; Jiang F; Cao S; Zhao B; Ding H; Dong T; Han X; Shang H
    BMC Immunol; 2022 Apr; 23(1):15. PubMed ID: 35366796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of HLA polymorphisms on the recognition of Gag epitopes in HIV-1 CRF01_AE infection.
    Sriwanthana B; Mori M; Tanaka M; Nishimura S; Miura T; Pathipvanich P; Sawanpanyalert P; Ariyoshi K
    PLoS One; 2012; 7(7):e41696. PubMed ID: 22848569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The differential ability of HLA B*5701+ long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences.
    Migueles SA; Laborico AC; Imamichi H; Shupert WL; Royce C; McLaughlin M; Ehler L; Metcalf J; Liu S; Hallahan CW; Connors M
    J Virol; 2003 Jun; 77(12):6889-98. PubMed ID: 12768008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preferential CTL targeting of Gag is associated with relative viral control in long-term surviving HIV-1 infected former plasma donors from China.
    Jia M; Hong K; Chen J; Ruan Y; Wang Z; Su B; Ren G; Zhang X; Liu Z; Zhao Q; Li D; Peng H; Altfeld M; Walker BD; Yu XG; Shao Y
    Cell Res; 2012 May; 22(5):903-14. PubMed ID: 22290423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Host HLA B*allele-associated multi-clade Gag T-cell recognition correlates with slow HIV-1 disease progression in antiretroviral therapy-naïve Ugandans.
    Serwanga J; Shafer LA; Pimego E; Auma B; Watera C; Rowland S; Yirrell D; Pala P; Grosskurth H; Whitworth J; Gotch F; Kaleebu P
    PLoS One; 2009; 4(1):e4188. PubMed ID: 19142234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of 2 HIV-1 Gag immunodominant epitopes restricted by Asian HLA allele HLA-B*4801.
    Murakoshi H; Kitano M; Akahoshi T; Kawashima Y; Dohki S; Oka S; Takiguchi M
    Hum Immunol; 2009 Mar; 70(3):170-4. PubMed ID: 19167445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-layered Gag-specific immunodominant responses contribute to improved viral control in the CRF01_AE subtype of HIV-1-infected MSM subjects.
    Jiang F; Han X; Zhang H; Zhao B; An M; Xu J; Chu Z; Dong T; Shang H
    BMC Immunol; 2016 Aug; 17(1):28. PubMed ID: 27577610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Immunodominance Hierarchy of CD8
    Adland E; Hill M; Lavandier N; Csala A; Edwards A; Chen F; Radkowski M; Kowalska JD; Paraskevis D; Hatzakis A; Valenzuela-Ponce H; Pfafferott K; Williams I; Pellegrino P; Borrow P; Mori M; Rockstroh J; Prado JG; Mothe B; Dalmau J; Martinez-Picado J; Tudor-Williams G; Frater J; Stryhn A; Buus S; Teran GR; Mallal S; John M; Buchbinder S; Kirk G; Martin J; Michael N; Fellay J; Deeks S; Walker B; Avila-Rios S; Cole D; Brander C; Carrington M; Goulder P
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29167337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequencies of Gag-restricted T-cell escape "footprints" differ across HIV-1 clades A1 and D chronically infected Ugandans irrespective of host HLA B alleles.
    Serwanga J; Nakiboneka R; Mugaba S; Magambo B; Ndembi N; Gotch F; Kaleebu P
    Vaccine; 2015 Mar; 33(14):1664-72. PubMed ID: 25728323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel immunodominant CD8+ T cell response restricted by a common HLA-C allele targets a conserved region of Gag HIV-1 clade CRF01_AE infected Thais.
    Buranapraditkun S; Hempel U; Pitakpolrat P; Allgaier RL; Thantivorasit P; Lorenzen SI; Sirivichayakul S; Hildebrand WH; Altfeld M; Brander C; Walker BD; Phanuphak P; Hansasuta P; Rowland-Jones SL; Allen TM; Ruxrungtham K
    PLoS One; 2011; 6(8):e23603. PubMed ID: 21887282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8
    Murakoshi H; Zou C; Kuse N; Akahoshi T; Chikata T; Gatanaga H; Oka S; Hanke T; Takiguchi M
    Retrovirology; 2018 Jul; 15(1):46. PubMed ID: 29970102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential escape patterns within the dominant HLA-B*57:03-restricted HIV Gag epitope reflect distinct clade-specific functional constraints.
    Payne RP; Branch S; Kløverpris H; Matthews PC; Koofhethile CK; Strong T; Adland E; Leitman E; Frater J; Ndung'u T; Hunter E; Haubrich R; Mothe B; Edwards A; Riddell L; Chen F; Harrigan PR; Brumme ZL; Mallal S; John M; Jooste JP; Shapiro R; Deeks SG; Walker BD; Brander C; Landis C; Carlson JM; Prado JG; Goulder PJ
    J Virol; 2014 May; 88(9):4668-78. PubMed ID: 24501417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV Controllers Exhibit Enhanced Frequencies of Major Histocompatibility Complex Class II Tetramer
    Laher F; Ranasinghe S; Porichis F; Mewalal N; Pretorius K; Ismail N; Buus S; Stryhn A; Carrington M; Walker BD; Ndung'u T; Ndhlovu ZM
    J Virol; 2017 Apr; 91(7):. PubMed ID: 28077659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human leucocyte antigen-Bw4 and Gag-specific T cell responses are associated with slow disease progression in HIV-1B-infected anti-retroviral therapy-naive Chinese.
    Li WH; Li CY; Yang HB; Zhang HP; Zhang X; Kong LS; Xu XN; Lu SC; Yan HP
    Clin Exp Immunol; 2013 Mar; 171(3):298-306. PubMed ID: 23379436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two Distinct Mechanisms Leading to Loss of Virological Control in the Rare Group of Antiretroviral Therapy-Naive, Transiently Aviremic Children Living with HIV.
    Vieira VA; Adland E; Grayson NE; Csala A; Richards F; Dacon C; Athavale R; Tsai MH; D'Souza R; Muenchhoff M; Bonsall D; Jooste P; Goulder PJR
    J Virol; 2022 Jan; 96(2):e0153521. PubMed ID: 34757843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. For protection from HIV-1 infection, more might not be better: a systematic analysis of HIV Gag epitopes of two alleles associated with different outcomes of HIV-1 infection.
    Luo M; Daniuk CA; Diallo TO; Capina RE; Kimani J; Wachihi C; Kimani M; Bielawny T; Peterson T; Mendoza MG; Kiazyk S; Ball TB; Plummer FA
    J Virol; 2012 Jan; 86(2):1166-80. PubMed ID: 22072744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of HLA-B*52:01-Driven Escape Mutations on Viral Replicative Capacity.
    Tsai MC; Singh S; Adland E; Goulder P
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32321820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CTL epitope distribution patterns in the Gag and Nef proteins of HIV-1 from subtype A infected subjects in Kenya: use of multiple peptide sets increases the detectable breadth of the CTL response.
    Currier JR; Visawapoka U; Tovanabutra S; Mason CJ; Birx DL; McCutchan FE; Cox JH
    BMC Immunol; 2006 Apr; 7():8. PubMed ID: 16620386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher homologous and lower cross-reactive Gag-specific T-cell responses in human immunodeficiency virus type 2 (HIV-2) than in HIV-1 infection.
    Jennes W; Camara M; Dièye T; Mboup S; Kestens L
    J Virol; 2008 Sep; 82(17):8619-28. PubMed ID: 18562522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.